Auro Pharma
Canadian subsidiary of an integrated pharmaceutical group. The company states a focus on research & development and on manufacturing drug intermediates, active pharmaceutical ingredients (APIs) and finished formulations. It operates a broad generic product portfolio across multiple therapeutic areas and provides pharmacovigilance/RMP services and regulatory submissions in Canada.
Industries
Nr. of Employees
medium (51-250)
Auro Pharma
Products
Generic finished-dosage pharmaceuticals
A catalogue of generic medicines in multiple therapeutic areas supplied as tablets, capsules and injectable vials/ampoules.
Generic finished-dosage pharmaceuticals
A catalogue of generic medicines in multiple therapeutic areas supplied as tablets, capsules and injectable vials/ampoules.
Services
Risk management plan implementation and adverse event reporting processes for marketed products.
Preparation and submission of regulatory dossiers for generic product approvals in Canada.
Risk management plan implementation and adverse event reporting processes for marketed products.
Preparation and submission of regulatory dossiers for generic product approvals in Canada.
Expertise Areas
- Generic pharmaceutical manufacturing
- API and intermediate production
- Formulation development for oral solids and parenterals
- Regulatory submissions and Health Canada approvals
Key Technologies
- Active pharmaceutical ingredient (API) synthesis
- Oral solid dosage formulation
- Parenteral/sterile vial formulation
- Pharmacovigilance and RMP systems
News & Updates
The company has published multiple Health Canada approval announcements for generic medicines.
The company has published multiple Health Canada approval announcements for generic medicines.